• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

能量调节候选基因单核苷酸多态性与乳腺癌的巢式病例对照研究

Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.

作者信息

Wang Yiting, McCullough Marjorie L, Stevens Victoria L, Rodriguez Carmen, Jacobs Eric J, Teras Lauren R, Pavluck Alexandre L, Thun Michael J, Calle Eugenia E

机构信息

Department of Epidemiology and Surveillance Research, American Cancer Society, 1599 Clifton Road NE, Atlanta, Georgia, GA 30329-4251, USA.

出版信息

Anticancer Res. 2007 Jan-Feb;27(1B):589-93.

PMID:17348446
Abstract

BACKGROUND

Accumulating evidence suggests that energy regulation, particularly insulin resistance, may influence breast cancer risk.

MATERIALS AND METHODS

The associations between single nucleotide polymorphisms (SNPs) in energy regulation candidate genes and postmenopausal breast cancer risk were evaluated. Conditional logistic regression was run on 488 matched case-control pairs from the American Cancer Society's Cancer Prevention Study II Nutrition Cohort. The studied SNPs were INS+1127 PstI (rs3842752), INSR H1085H (rs1799817) and PPARy Prol2Ala (rs1801282).

RESULTS

A significantly lower breast cancer risk was found among women homozygous for the T allele of INSR H1085H. A marginally significant increased risk of breast cancer was observed among women homozygous for the Ala allele of PPARgamma Pro12Ala. No significant association was observed between INS+ 1127 PstI and breast cancer risk.

CONCLUSION

Our results suggest that polymorphisms in these energy regulation candidate genes may be associated with risk of breast cancer, but replication in larger studies is needed.

摘要

背景

越来越多的证据表明,能量调节,尤其是胰岛素抵抗,可能会影响乳腺癌风险。

材料与方法

评估能量调节候选基因中的单核苷酸多态性(SNP)与绝经后乳腺癌风险之间的关联。对美国癌症协会癌症预防研究II营养队列中的488对匹配病例对照进行条件逻辑回归分析。研究的SNP包括胰岛素基因+1127 PstI(rs3842752)、胰岛素受体基因H1085H(rs1799817)和过氧化物酶体增殖物激活受体γ基因Pro12Ala(rs1801282)。

结果

胰岛素受体基因H1085H的T等位基因纯合女性患乳腺癌的风险显著降低。过氧化物酶体增殖物激活受体γ基因Pro12Ala的Ala等位基因纯合女性患乳腺癌的风险略有增加。胰岛素基因+1127 PstI与乳腺癌风险之间未观察到显著关联。

结论

我们的结果表明,这些能量调节候选基因中的多态性可能与乳腺癌风险相关,但需要在更大规模的研究中进行验证。

相似文献

1
Nested case-control study of energy regulation candidate gene single nucleotide polymorphisms and breast cancer.能量调节候选基因单核苷酸多态性与乳腺癌的巢式病例对照研究
Anticancer Res. 2007 Jan-Feb;27(1B):589-93.
2
Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.维生素D通路基因多态性、饮食与绝经后乳腺癌风险:一项巢式病例对照研究
Breast Cancer Res. 2007;9(1):R9. doi: 10.1186/bcr1642.
3
Association of polymorphisms in the paraoxonase 1 gene with breast cancer incidence in the CPS-II Nutrition Cohort.对氧磷酶1基因多态性与癌症预防研究二期营养队列中乳腺癌发病率的关联
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1226-8. doi: 10.1158/1055-9965.EPI-05-0930.
4
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.维生素D受体基因多态性与乳腺癌风险:来自美国国立癌症研究所乳腺癌和前列腺癌队列联盟的结果。
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539.
5
Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women.丹麦绝经后女性中谷胱甘肽S-转移酶A1和O1的多态性与乳腺癌
Eur J Cancer Prev. 2008 Jun;17(3):225-9. doi: 10.1097/CEJ.0b013e3282b6fe1e.
6
ERCC4 associated with breast cancer risk: a two-stage case-control study using high-throughput genotyping.ERCC4与乳腺癌风险相关:一项使用高通量基因分型的两阶段病例对照研究。
Cancer Res. 2006 Oct 1;66(19):9420-7. doi: 10.1158/0008-5472.CAN-06-1418.
7
Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland.在马里兰州华盛顿县的一组女性中,乳腺癌风险与着色性干皮病基因的多态性形式无关。
Breast Cancer Res Treat. 2007 Jan;101(1):65-71. doi: 10.1007/s10549-006-9263-3. Epub 2006 Jul 6.
8
MDR1 C3435T polymorphism in patients with breast cancer.乳腺癌患者的多药耐药基因1(MDR1)C3435T多态性
Arch Med Res. 2007 Jul;38(5):539-44. doi: 10.1016/j.arcmed.2007.02.005. Epub 2007 Apr 26.
9
SNPs in ultraconserved elements and familial breast cancer risk.超保守元件中的单核苷酸多态性与家族性乳腺癌风险
Carcinogenesis. 2008 Feb;29(2):351-5. doi: 10.1093/carcin/bgm290. Epub 2008 Jan 3.
10
Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer.叶酸代谢酶和转运蛋白的多态性与乳腺癌风险
Breast Cancer Res Treat. 2008 Dec;112(3):585-93. doi: 10.1007/s10549-008-9895-6. Epub 2008 Jan 19.

引用本文的文献

1
Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.在中国东部人群中,PPARγ、PPARGC1A 和 PPARGC1B 基因变异与胃癌易感性的关联。
BMC Med Genomics. 2022 Dec 31;15(1):274. doi: 10.1186/s12920-022-01428-0.
2
Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.过氧化物酶体增殖物激活受体γ Pro12Ala/C161T 基因型及改变乳腺癌风险的危险单倍型:一项土耳其病例对照研究
Biochem Genet. 2021 Dec;59(6):1413-1426. doi: 10.1007/s10528-021-10068-5. Epub 2021 Apr 24.
3
Genetic variation in TNFα, PPARγ, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort.
TNFα、PPARγ 和 IRS-1 基因的遗传变异及其与 HEAL 队列中乳腺癌生存的关系。
Breast Cancer Res Treat. 2018 Apr;168(2):567-576. doi: 10.1007/s10549-017-4621-x. Epub 2017 Dec 18.
4
Genetic Variants in Metabolic Signaling Pathways and Their Interaction with Lifestyle Factors on Breast Cancer Risk: A Random Survival Forest Analysis.代谢信号通路中的遗传变异及其与生活方式因素对乳腺癌风险的交互作用:随机生存森林分析。
Cancer Prev Res (Phila). 2018 Jan;11(1):44-51. doi: 10.1158/1940-6207.CAPR-17-0143. Epub 2017 Oct 26.
5
Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.与胰岛素样生长因子-I和胰岛素抵抗相关的基因变异及特征,以及它们与生活方式对绝经后结直肠癌风险的相互作用。
PLoS One. 2017 Oct 12;12(10):e0186296. doi: 10.1371/journal.pone.0186296. eCollection 2017.
6
Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study.药物遗传多态性作为老年多重用药患者频繁住院的独立危险因素:一项试点研究。
Pharmgenomics Pers Med. 2016 Oct 14;9:107-116. doi: 10.2147/PGPM.S117014. eCollection 2016.
7
Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.过氧化物酶体增殖物激活受体γ(PPARG)rs1801282 C>G多态性与亚洲人癌症易感性相关:一项更新的荟萃分析。
Int J Clin Exp Med. 2015 Aug 15;8(8):12661-73. eCollection 2015.
8
Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.过氧化物酶体增殖物激活受体γ(PPARG)基因多态性与乳腺癌易感性:一项荟萃分析。
Int J Clin Exp Med. 2015 Aug 15;8(8):12226-38. eCollection 2015.
9
Insulin receptor variants and obesity-related cancers in the Framingham Heart Study.弗雷明汉心脏研究中的胰岛素受体变体与肥胖相关癌症
Cancer Causes Control. 2015 Aug;26(8):1189-95. doi: 10.1007/s10552-015-0613-5. Epub 2015 Jun 16.
10
Genetic variation in peroxisome proliferator-activated receptor gamma, soy, and mammographic density in Singapore Chinese women.新加坡华族妇女中过氧化物酶体增殖物激活受体 γ、大豆和乳腺 X 线摄影密度的遗传变异。
Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):635-44. doi: 10.1158/1055-9965.EPI-11-1042. Epub 2012 Feb 1.